Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Ester Pungolino, Silvia Cantoni, Cecilia Del Curto, Cristina Gabutti, Marianna Caramella, Luciana Barbarano, Michela Draisci, Enrica Morra

Blood (2008) 112 (11): 4884.

https://doi.org/10.1182/blood.V112.11.4884.4884

Published: 2008

Journal Articles

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Ester Pungolino, MD, Silvia Cantoni, MD, Cecilia Del Curto, MD, Livio Gargantini, MD, Marianna Caramella, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Michela Draisci, MD, Cristina Gabutti, MD, Simona Paratore, MD, Karen Lanza, BD, Sonia Ribera, MD, Enrica Morra, MD

Blood (2007) 110 (11): 4577.

https://doi.org/10.1182/blood.V110.11.4577.4577

Published: 2007

Journal Articles

Combination of Fludarabine (FAMP) Cyclophosphamide (CTX) and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL).

Alessandra Tedeschi, Marco Montillo, Sara Miqueleiz, Michela Draisci, Francesca Ricci, Barbara Scarpati, Mariangela Mura, Monica Crugnola, Enrica Morra

Blood (2005) 106 (11): 5036.

https://doi.org/10.1182/blood.V106.11.5036.5036

Published: 2005

Journal Articles

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Ester Pungolino, MD, Michela Draisci, MD, Livio Gargantini, MD, Renata Farioli, PhD, Valentina Rossi, MD, Paola Cozzi, MD, Sara Miqueleiz Alamos, MD, Anna Maria Cafro, MD, Enrica Morra, MD

Blood (2004) 104 (11): 4690.

https://doi.org/10.1182/blood.V104.11.4690.4690

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Combination of Fludarabine (FAMP) Cyclophosphamide (CTX) and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL).

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Email alerts

ASH Publications

American Society of Hematology

Update search

Coexistence of Trisomy 8 as Both Clonal and Adjunctive Cytogenetic Abnormality in Philadelphia-Positive (Ph+) Chronic Myeloid Leukemia (CML) Patients on Treatment with Tirosine Kinase Inhibitors (TKIs): Report of Two Cases

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Combination of Fludarabine (FAMP) Cyclophosphamide (CTX) and Alemtuzumab for Patients with Relapsed Chronic Lymphocytic Leukemia (CLL).

Mobilization of Ph-Negative Peripheral Blood Stem Cells (PBSCs) with rHu-G-CSF in Chronic Myeloid Leukemia (CML) Patients Achieving Complete Cytogenetic Response with Imatinib Mesilate (Glivec).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only